Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target?

Documents similaires

• Increasing excess to weight loss injection shown to save thousands of lives a year
  par: Iskandar Idris
  Publié: (2024)
• Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
  par: Iskandar Idris
  Publié: (2024)
• The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
  par: Iskandar Idris
  Publié: (2024)
• Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
  par: Iskandar Idris
  Publié: (2024)
• Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea
  par: Iskandar Idris
  Publié: (2024)